The president's negotiated deal with the drugmakers will allow Medicare and Medicaid coverage for Lilly's Zepbound and Novo's Wegovy, according to reports, as well as offer discounted prices directly to consumers through the federal government's direct-to-consumer website, TrumpRx, which is set to launch in 2026
Current landscape of phosphodiesterase 10A (PDE10A) inhibition
Call Boesen Law today at (303) 999-9999 for a free, no-obligation consultation
However, the structurally modified version of the tetra-substituted peptide, Modified GRF 1-29, is considered to boast a longer half-life and has, therefore, been considered by researchers as a more viable compound for use during experimental research
These outcomes were assessed as the changes in 1st- and 2nd-year follow-up from baseline